GLPBio

PP185

Catalog No.: GC81317Purity:>98.00%
PP185 is a insulin receptor kinase substrate.

Les produits sont exclusivement destinés à la recherche. Ils ne doivent pas être utilisés chez l’être humain. Nous ne vendons pas aux patients.


PP185
Cas No.: 851176-40-4
10mgIn Stock
$11.00
1
25mgIn Stock
$22.00
1
50mgIn Stock
$35.00
1
100mgIn Stock
$57.00
1

Citations

Aucune citation n’est actuellement disponible pour ce produit. Vous trouverez ci-dessous une sélection de publications citant des produits GlpBio.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Description

PP185 is a insulin receptor kinase substrate. PP185 undergoes rapid tyrosine phosphorylation, with activity dependent on divalent cations and inhibited by insulin receptor kinase domain antibodies. PP185 can be used for the research of neuroblastoma [1] [2] [3].

In Vitro, PP185 (0.4-200 μM; 1 h) engages an increasing number of cysteine sites in HEK293T cell lysates as its concentration increases, with detectable liganding events observed at higher concentrations[1]. PP185 is phosphorylated in a rapid and dose-dependent manner induced by both Insulin and IGF-I in mouse neuroblastoma N18 cells, with maximal phosphorylation at 1 min and rapid dephosphorylation thereafter[2]. PP185 from rat H-35 hepatoma cells has tyrosine phosphorylation in a cell-free system inhibited by anti-IRK (a site-specific antibody targeting insulin receptor kinase)[3]. PP185 in rat H-35 hepatoma cells undergoes rapid tyrosine phosphorylation induced by insulin treatment[3].

References:
[1]. Biggs GS,et al. Robust proteome profiling of cysteine-reactive fragments using label-free chemoproteomics. Nat Commun. 2025 Jan 2;16(1):73.
[2]. Shemer J, et al. Insulin and insulin-like growth factor-I stimulate a common endogenous phosphoprotein substrate (pp185) in intact neuroblastoma cells. J Biol Chem. 1987;262(32):15476-15482.
[3]. Tashiro-Hashimoto Y, et al. Tyrosine phosphorylation of pp185 by insulin receptor kinase in a cell-free system. J Biol Chem. 1989;264(12):6879-6885.

Documents produit (Product Documents)

Purity:>98.00%Appearance:A solid

Propriétés chimiques (Chemical Properties)

N° CAS
851176-40-4
Formule moléculaire
C11H14ClNO2
Masse moléculaire
227.69
Conservation
Store at -20°C
Conditions d’expédition
Les échantillons d’évaluation sont expédiés avec des blocs réfrigérants. Les autres formats sont expédiés à température ambiante ou, sur demande, avec des blocs réfrigérants.

Calculateurs (Calculators)Molarité / Dilution / Masse moléculaire / Conversion d’unités / Formulation in vivo / Solubilité

g/mol

Reviews

Review for PP185

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%